Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of Neurology|April 12, 2024
Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseasesThyago R Cardim-Pires, Aurélie de Rus Jacquet, Francesca CicchettiNeuroscience Letters|November 5, 2017
The effects of cysteamine in a mouse model of levodopa-induced dyskinesiasLinda S David, Martine Saint-Pierre, Jérôme Lamontagne-Proulx, et al.Molecular Psychiatry|January 26, 2021
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disordersAurélie de Rus Jacquet, Hélèna L Denis, Francesca Cicchetti, et al.Journal of Neurochemistry|June 24, 2010
Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseasesMélanie Bousquet, Claire Gibrat, Mélissa Ouellet, et al.Frontiers in Neurology|December 17, 2020
Targeting Tau to Treat Clinical Features of Huntington's DiseaseMaria Masnata, Shireen Salem, Aurelie de Rus Jacquet, et al.Brain, Behavior, and Immunity|January 4, 2014
The different effects of LPS and poly I:C prenatal immune challenges on the behavior, development and inflammatory responses in pregnant mice and their offspringDany Arsenault, Isabelle St-Amour, Giulia Cisbani, et al.Journal of Neurochemistry|August 9, 2006
Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older ratsMartine Saint-Pierre, Marie-Eve Tremblay, Attila Sik, et al.Journal of Neuroinflammation|October 13, 2011
The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degenerationJanelle Drouin-Ouellet, Claire Gibrat, Mélanie Bousquet, et al.Journal of Neurochemistry|May 22, 2009
Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusionsClaire Gibrat, Martine Saint-Pierre, Mélanie Bousquet, et al.Brain : a Journal of Neurology|October 26, 2017
Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's diseaseGiulia Cisbani, Alexander Maxan, Jeffrey H Kordower, et al.Pageof 9